ICONIMAC - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
88054356
Word Mark
ICONIMAC
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-09-21
Filing Date
2018-07-26
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-12-25
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
CORWIN, CHARLOTTE K
Statements
Goods and Services
Pharmaceuticals for the purpose of treating life-threatening diseases; pharmaceuticals for use in the fields of biotechnology and immune therapeutics; pharmaceutical products, namely, innate immunity cell-based therapeutics; pharmaceuticals for the treatment of infectious disease, autoimmunity, neurodegeneration, and aging; pharmaceuticals for addressing underlying innate immune dysfunction, including in connection with infectious diseases, autoimmune diseases, neurologic diseases, cancer, Parkinson's, Alzheimer's, and dementia; pharmaceuticals for addressing a wide variety of diseases, including pulmonary diseases, fibrosis, and protein aggregation diseases; pharmaceutical preparations, namely, cell-based therapeutics to augment innate immune responses; pharmaceutical preparations, namely, a drug delivery system for the continuous release of a wide variety of therapeutic agents; vaccines; vaccine preparations
Goods and Services
Biotechnology research; immune therapeutics research; research and development in the biotechnology and immune therapeutics fields; development of new technology in the field of biotechnology to augment innate immune responses; development of new biotechnology, namely, using augmented innate immune responses to promote the treatment of infectious disease, autoimmunity, neurodegeneration, and aging; development of new biotechnology, namely, pharmaceuticals for addressing underlying innate immune dysfunction, including in connection with infectious diseases, autoimmune diseases, neurologic diseases, cancer, Parkinson's, Alzheimer's, and dementia; development of new biotechnology, namely, pharmaceuticals for addressing a wide variety of diseases, including pulmonary diseases, fibrosis, and protein aggregation diseases; conducting clinical trials in the field of biotechnology; clinical research in the field of immune therapeutics; clinical research in the field of vaccines; research and development of vaccines and medicines; conducting research and clinical trials relating to innate immunity cell-based therapeutics; medical research services in the fields of biotechnology and immune therapeutics
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-08-01
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-08-01
Primary Code
042
Correspondences
Name
Aaron D. Hendelman
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2018-07-30 | NEW APPLICATION ENTERED IN TRAM |
| 2018-08-01 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-11-13 | ASSIGNED TO EXAMINER |
| 2018-11-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2018-12-05 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2018-12-25 | PUBLISHED FOR OPPOSITION |
| 2018-12-25 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-02-19 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2019-06-10 | TEAS EXTENSION RECEIVED |
| 2019-06-10 | EXTENSION 1 FILED |
| 2019-06-10 | EXTENSION 1 GRANTED |
| 2019-06-12 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-02-14 | TEAS EXTENSION RECEIVED |
| 2020-02-14 | EXTENSION 2 FILED |
| 2020-02-14 | EXTENSION 2 GRANTED |
| 2020-02-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-03-02 | ASSIGNED TO EXAMINER |
| 2020-09-21 | ABANDONMENT - NO USE STATEMENT FILED |
| 2020-09-21 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
